- Non-invasive tests-based risk stratification: Baveno VII and beyond
-
Semmler G, Jachs M, Mandorfer M
- KMID: 2538205
- Clin Mol Hepatol.
- 2023 Jan;29(1):105-109.
- doi: 10.3350/cmh.2022.0361
-
- CITED
-
- Close
- SHARE
-
- Close
- Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
-
Semmler G, Datz C, Trauner M
- KMID: 2539805
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S244-S260.
- doi: 10.3350/cmh.2022.0364
Nutrition and dietary interventions are a central component in the pathophysiology, but also a cornerstone in the management of patients with non-alcoholic fatty liver disease (NAFLD). Summarizing our rapidly advancing... -
- CITED
-
- Close
- SHARE
-
- Close
- Two-dimensional shear wave elastography (ElastQ) accurately rules out liver fibrosis and rules in advanced chronic liver disease across liver disease etiologies: a prospective multicenter study
-
Bauer DJM, SilvestriI AD, Mare R, Maiocchi L, Raimondi A, Semmler G, Mandorfer M, Sporea I, Ferraioli G, Reiberger T
- KMID: 2546452
- Ultrasonography.
- 2023 Oct;42(4):544-554.
- doi: 10.14366/usg.23069
Purpose: This study evaluated ElastQ, a two-dimensional shear wave elastography (2D-SWE) technique, for the non-invasive assessment of liver fibrosis risk using liver stiffness measurement (LSM). The aim was to determine... -
- CITED
-
- Close
- SHARE
-
- Close
